Overexpression of DNA methyltransferase 1 as a negative independent prognostic factor in primary gastrointestinal diffuse large B-cell lymphoma treated with CHOP-like regimen and rituximab

By              

Oncology Letters, Vol. 9, Iss. 5, 2015-01 ,pp. : 2307-2312

Spandidos Publications

Access to resources Recommend Favorite

Prognostic Significance of Survivin and Caspase-3 Immunohistochemical Expression in Patients with Diffuse Large B-cell Lymphoma Treated with Rituximab and CHOP

By Mitrović Zdravko  

Pathology & Oncology Research, Vol. 17, Iss. 2, 2011-06 ,pp. : 243-247

Springer Publishing Company

Access to resources Recommend Favorite

Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP

By Hara Takeshi   Tsurumi Hisashi   Goto Naoe   Kanemura Nobuhiro   Yoshikawa Takeshi   Kasahara Senji   Yamada Toshiki   Sawada Michio   Goto Hideko   Fukuno Kenji   Kitagawa Jun-ichi   Yasuda Ichiro   Katsumura Naoki   Takemura Masao   Takahashi Takeshi   Takami Tsuyoshi   Moriwaki Hisataka  

Journal of Cancer Research and Clinical Oncology, Vol. 135, Iss. 10, 2009-10 ,pp. : 1421-1428

Springer Publishing Company

Access to resources Recommend Favorite

Long-term follow-up of localized, primary gastric diffuse large B-cell lymphoma treated with rituximab and CHOP

By                                    

Experimental and Therapeutic Medicine, Vol. 3, Iss. 2, 2012-01 ,pp. : 304-308

Spandidos Publications

Access to resources Recommend Favorite

Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP

By Shikata Hisaharu   Yakushijin Yoshihiro   Yamanouchi Jun   Azuma Taichi   Yasukawa Masaki  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 178-185

Springer Publishing Company

Access to resources Recommend Favorite